Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 0.06% is 100% above its 5-year average of -16.66%, near the high end of its 5-year range (-45.43%–9.00%).
98.61% below its 12-month average of 4.31%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): 9.00%.
EBITDA MARGIN
0.06%
EBITDA MARGIN AVG TTM
4.31%
EBITDA MARGIN AVG 3Y
-7.56%
EBITDA MARGIN AVG 5Y
-16.66%
EBITDA MARGIN AVG 10Y
-18.76%
EBITDA MARGIN AVG 15Y
-13.42%
EBITDA MARGIN AVG 20Y
-12.16%
CURRENT VS TTM AVG
-98.61%
CURRENT VS 3Y AVG
+100.79%
CURRENT VS 5Y AVG
+100.36%
CURRENT VS 10Y AVG
+100.32%
CURRENT VS 15Y AVG
+100.45%
CURRENT VS 20Y AVG
+100.49%
Alphatec Holdings, Inc.
Market Cap
$1.65B
EBITDA Margin
0.06%
TTM Avg
4.31%
3Y Avg
-7.56%
5Y Avg
-16.66%
Market Cap
$1.65B
EBITDA Margin
19.54%
TTM Avg
15.33%
3Y Avg
15.07%
5Y Avg
12.91%
Market Cap
$1.71B
EBITDA Margin
16.41%
TTM Avg
1.22%
3Y Avg
-1.65%
5Y Avg
4.31%
Market Cap
$1.76B
EBITDA Margin
1.15%
TTM Avg
-0.80%
3Y Avg
-3.79%
5Y Avg
-4.67%
Market Cap
$1.52B
EBITDA Margin
5.15%
TTM Avg
0.72%
3Y Avg
-7.50%
5Y Avg
-11313.48%
Market Cap
$1.78B
EBITDA Margin
-628.14%
TTM Avg
-766.74%
3Y Avg
-948.44%
5Y Avg
-801.32%
Market Cap
$1.78B
EBITDA Margin
-695.72%
TTM Avg
-791.65%
3Y Avg
-791.65%
5Y Avg
-791.65%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alphatec Holdings, Inc. (ATEC) | $1.65B | 0.06% | 4.31% | -7.56% | -16.66% |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.65B | 19.54% | 15.33% | 15.07% | 12.91% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.71B | 16.41% | 1.22% | -1.65% | 4.31% |
| Certara, Inc. (CERT)vs › | $1.57B | 18.52% | 17.87% | 16.34% | 15.57% |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.76B | 1.15% | -0.80% | -3.79% | -4.67% |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.52B | 5.15% | 0.72% | -7.50% | -11313.48% |
| GH Research PLC (GHRS)vs › | $1.52B | N/A | N/A | N/A | N/A |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.78B | -628.14% | -766.74% | -948.44% | -801.32% |
| Generate Biomedicines, Inc. (GENB)vs › | $1.78B | -695.72% | -791.65% | -791.65% | -791.65% |
| Braveheart Bio, Inc. (BRVE)vs › | $1.51B | N/A | N/A | N/A | N/A |
Gross Margin
66.2%
EBITDA Margin
0.1%
Operating Margin
-5.5%
Net Margin
-13.5%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | 9.00% |
| 2026-03-31 | -0.83% |
| 2025-12-31 | 7.10% |
| 2025-09-30 | 2.26% |
| 2025-06-30 | 4.01% |
| 2025-03-31 | -13.66% |
| 2024-12-31 | -1.36% |
| 2024-09-30 | -7.82% |
| 2024-06-30 | -9.78% |
| 2024-03-31 | -17.64% |
| 2023-12-31 | -20.20% |
| 2023-09-30 | -19.20% |
| 2023-06-30 | -30.21% |
| 2023-03-31 | -22.41% |
| 2022-12-31 | -21.56% |
| 2022-09-30 | -26.00% |
| 2022-06-30 | -23.42% |
| 2022-03-31 | -31.48% |
| 2021-12-31 | -38.78% |
| 2021-09-30 | -42.54% |
| 2021-06-30 | -45.43% |
| 2021-03-31 | -32.13% |
| 2020-12-31 | -32.03% |
| 2020-09-30 | -23.73% |
| 2020-06-30 | -27.97% |
| 2020-03-31 | -50.12% |
| 2019-12-31 | -37.94% |
| 2019-09-30 | -39.13% |
| 2019-06-30 | -37.49% |
| 2019-03-31 | -35.69% |
| 2018-12-31 | -29.63% |
| 2018-09-30 | -25.83% |
| 2018-06-30 | -22.48% |
| 2018-03-31 | 5.72% |
| 2017-12-31 | -6.33% |
| 2017-09-30 | 2.32% |
| 2017-06-30 | 4.66% |
| 2017-03-31 | -5.47% |
| 2016-12-31 | -25.44% |
| 2016-09-30 | -5.72% |
| 2016-06-30 | 5.33% |
| 2016-03-31 | 0.32% |
| 2015-12-31 | -10.45% |
| 2015-09-30 | -373.14% |
| 2015-06-30 | -3.85% |
| 2015-03-31 | 10.90% |
| 2014-12-31 | 7.64% |
| 2014-09-30 | 12.12% |
| 2014-06-30 | 12.31% |
| 2014-03-31 | 0.30% |
| 2013-12-31 | -103.28% |
| 2013-09-30 | -23.91% |
| 2013-06-30 | -3.43% |
| 2013-03-31 | -0.27% |
| 2012-12-31 | -5.21% |
| 2012-09-30 | 8.17% |
| 2012-06-30 | -6.72% |
| 2012-03-31 | 11.71% |
| 2011-12-31 | -23.33% |
| 2011-09-30 | -3.82% |
| 2011-06-30 | -5.41% |
| 2011-03-31 | 5.31% |
| 2010-12-31 | 6.73% |
| 2010-09-30 | 2.54% |
| 2010-06-30 | -5.70% |
| 2010-03-31 | -0.18% |
| 2009-12-31 | 8.16% |
| 2009-09-30 | 7.62% |
| 2009-06-30 | -7.92% |
| 2009-03-31 | -1.71% |
| 2008-12-31 | -4.76% |
| 2008-09-30 | -8.57% |
| 2008-06-30 | -7.05% |
| 2008-03-31 | -59.60% |
| 2007-12-31 | -38.49% |
| 2007-09-30 | -12.92% |
| 2007-06-30 | 10.50% |
| 2007-03-31 | -1.03% |
| 2006-12-31 | -29.71% |
| 2006-09-30 | -20.91% |
| 2006-06-30 | -10.90% |
| 2006-03-31 | -9.14% |
| 2005-12-31 | -385.85% |
| 2005-09-30 | 100.00% |
| 2005-06-30 | 100.00% |
| 2005-03-31 | 100.00% |
| 2004-12-31 | -296.01% |
| 2004-09-30 | 100.00% |
| 2004-06-30 | 100.00% |
| 2004-03-31 | 100.00% |
